AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 20877474.
- Also identified by DOI 10.1371/journal.pmed.1000331 and PMC identifier 2943436.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The HIV/AIDS pandemic continues to spread and an AIDS vaccine is urgently needed. Regional alliances and international collaborations can foster the development and evaluation of the next generation of AIDS vaccine candidates. The importance of coordinating and harmonizing efforts across regional alliances has become abundantly clear. We recently formed the AIDS Vaccine for Asia Network (AVAN) to help facilitate the development of a regional AIDS vaccine strategy that accelerates research and development of an AIDS vaccine through government advocacy, improved coordination, and harmonization of research; develops clinical trial and manufacturing capacity; supports ethical and regulatory frameworks; and ensures community participation.
Medical subject headings
- AIDS Vaccines
- HIV Infections